Danhong Chen, Ran Xu, Xiaoyun Ye, Youmei Xiao, Mengfan Wang, Wanqiong Li, Feiyu Luo, Xiaoshuang Niu, Xia Yang, Ye Su, Wenxuan Zeng, Ying Liu, Wenzhi Shang, Yang Li, Xin Zhao, J Hu, Xiaoshuang Chen, Xueqin Zhu, Xinghua Sui, Yanfeng Gao
T cell infiltration and activation in anti-PD-1-resistant tumor model. The BsPNEC platform integrates tumor-targeted delivery, magnetic resonance imaging (MRI) contrast capabilities, and robust inhibition of tumor growth. Our findings present a synergistic immunotherapeutic strategy that simultaneously skews immunosuppressive TME and amplifies T cell immune response.